8ª Edição – Especial Simpósio

Session at the 8th Oncoclinicas International Symposium highlights peculiarities on each subtype of head and neck cancer

por: Grupo Oncoclínicas
Session at the 8th Oncoclinicas International Symposium highlights peculiarities on each subtype of head and neck cancer

Comissão científica

Bruno Ferrari
Bruno Ferrari
Carlos Gil
Carlos Gil
Paula Ugalde
Paula Ugalde
Sérgio Azevedo
Sérgio Azevedo

Colaboradores

Leonardo Rangel
Leonardo Rangel
Pedro de Marchi
Pedro de Marchi

According to oncologist Pedro de Marchi, leader of head and neck specialities at Oncoclinicas Group, “this isn’t just a type of cancer. There’s several subtypes of this illness, and their treatments get more and more specific”. De Marchi, who also coordinated the session, says that although it’s a challenging neoplasm, the treatment has evolved, allowing patients to live longer and have access to increasingly less toxic, less invasive therapy.

Leonardo Rangel, coordinator of Neck and Head Surgery at Rio de Janeiro State University (UERJ), was responsible for the endoscopic thyroidectomy on a thyroid cancer patient during the event. The surgeon also mentions Brazil is one of the countries that adopted the technique the most but, confronted to the surgery totals, it’s still hardly used: “thyroid surgery in Brazil averages around 50 to 60 thousand a year. Around 500 are performed with this technique”.

To read the article and full covering of the 8th Oncoclinicas International Symposium, access our website.

Acesse o artigo completo deste estudo
Download
Compartilhe
Ou compartilhe o link
Link copiado para sua área de trabalho.L